Precision for Medicine - Suspicious for NMIBC (Non-Muscle Invasive Bladder Cancer)

  • Study Sponsor and Protocol Number: 
    Precision for Medicine - ONC-62
  • Specialty:
    Oncology/Internal Medicine
  • Type:
    Biospecimen (urine only)
  • Inclusion:
    Age 18 and up
    Scheduled to undergo a cystoscopy with biopsy or TURBT within the next 14 days
  • Exclusion:
    Bladder biopsy within the last 6 months
    • Chemotherapy within the last 6 months
    Immunotherapy including BCG within the last 2 years